期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 204, 期 11, 页码 2705-2718出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20071267
关键词
-
资金
- NIAID NIH HHS [AI-057996, R01 AI057996] Funding Source: Medline
CD38 controls the chemotaxis of leukocytes to some, but not all, chemokines, suggesting that chemokine receptor signaling in leukocytes is more diverse than previously appreciated. To determine the basis for this signaling heterogeneity, we examined the chemokine receptors that signal in a CD38-dependent manner and identified a novel alternative chemokine receptor signaling pathway. Similar to the classical signaling pathway, the alternative chemokine receptor pathway is activated by G alpha(i2)-containing Gi proteins. However, unlike the classical pathway, the alternative pathway is also dependent on the Gq class of G proteins. We show that G alpha(q)-deficient neutrophils and dendritic cells (DCs) make defective calcium and chemotactic responses upon stimulation with N-formyl methionyl leucyl phenylalanine and CC chemokine ligand (CCL) 3 ( neutrophils), or upon stimulation with CCL2, CCL19, CCL21, and CXC chemokine ligand ( CXCL) 12 ( DCs). In contrast, G alpha(q)-deficient T cell responses to CXCL12 and CCL19 remain intact. Thus, the alternative chemokine receptor pathway controls the migration of only a subset of cells. Regardless, the novel alternative chemokine receptor signaling pathway appears to be critically important for the initiation of inflammatory responses, as G alpha(q) is required for the migration of DCs from the skin to draining lymph nodes after fluorescein isothiocyanate sensitization and the emigration of monocytes from the bone marrow into inflamed skin after contact sensitization.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据